COMPANY PROFILE

GemPharmatech / 集萃药康

Explore full profile

Nanjing STAR-listed engineered mouse-model OEM — STAR 688046

Nanjing City, ChinaFounded 2017Biotech & Life Sciences

Valuation $250–500M Last recorded · 2020

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About GemPharmatech / 集萃药康

Nanjing STAR-listed genetically engineered mouse-model OEM (GemPharmatech / 集萃药康; STAR 688046) offering 22,000+ engineered strains, Spot-Mouse KO catalog, humanized / germ-free models and preclinical efficacy services. Mid-size China animal-model leftover beyond Cyagen Santa Clara soft-skip / JOINN Mon DNR. Founded 2017; Jiangbei New Area HQ (city-level Nanjing — replace false Dongcheng District pin). YE2025 filing-class ~760 staff — band 501-1000. Soft-skip inventing 1001-5000 from stale directory / street pin / Vazyme 688105 ticker confusion.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Nanjing City, China
Employees: 106
Open positions: None listed
Dealroom signal: 44.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Sep 2020	$59M	$234M	Morgan Stanley · YunFeng Capital · GL Ventures · Sequoia	—
SERIES AOther financing	Jul 2019	$23M	$93M	CDH Investments · Sinopharm Group	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

GemPharmatech / 集萃药康 website traffic

Latest recorded traffic for GemPharmatech / 集萃药康 is 25K monthly website visits, down 64.3% over the last three months. GemPharmatech / 集萃药康's team grew 7.1% over the past year.

Latest monthly visits25K 3-month web change-64.3% 1-year team growth+7.1%

Monthly website visitsJan 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Research Associate I/IISan Diego, CA · Other · Sep 5, 2026 Academic Business Development Manager - Midwest US TerritoryBeijing, Dongcheng District, Beijing, 100010, China · Business Development · Jul 26, 2026 Academic Business Development Manager - Southeast US TerritoryBeijing, Dongcheng District, Beijing, 100010, China · Business Development · Jul 25, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RBRidge BiotechnologiesAI-enabled platform for precision enzyme and drug design	Palo Alto, United States	Operational	15	$25M	$100M
DPDISCO PharmaceuticalsBiotechnological research as well as the development, production and distribution of biotechnological products and solutions of all kinds	Cologne, Germany	Operational
VIVilyaDeveloping a novel class of drugs that precisely target the biology of disease	Seattle, United States	Operational
STSeismic TherapeuticThe Machine Learning Immunology Company	Cambridge, United States	Operational
HOHolloidProvides real-time multi-dimensional data on colloids, based on 3D imaging, with the throughput of cytometry	Vienna, Austria	Operational
OBOctarine BioHarnessing the powers of synthetic biology to develop rare and superior cannabinoids and psychedelic derivatives	Copenhagen, Denmark	Operational
CECellSpringThe Next Level in 3D Cell Culture	Zurich, Switzerland	Operational
TSTheranosis Life SciencesA fully functioning cell culture facility and molecular biology setup	Hyderabad, India	Operational